Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1658 1675
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17638483 | PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDES | Final Rejection | Novo Nordisk A/S |
| 18562949 | ASSESSING AND TREATING OBESITY | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18020908 | N-ACYL AMINO ACID PRODUCTS AND USES | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18546483 | GIP/GLP1 DUAL AGONIST THERAPEUTIC METHODS | Non-Final OA | Eli Lilly and Company |
| 18745091 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39) | Final Rejection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18703595 | Neuregulin for Protection Against Respiratory Viral Infection and Post-Viral Disease | Non-Final OA | THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18255136 | METHODS AND USES FOR NDFIP1 FUSION POLYPEPTIDES IN TREATING NEURODEGENERATIVE DISEASES, BRAIN AND/OR TRAUMATIC AND NON-TRAUMATIC SPINAL CORD INJURIES, AND/OR OPTIC NEUROPATHIES | Non-Final OA | University Health Network |
| 18574665 | PEPTIDE HAVING OBESITY AND MUSCLE LOSS INHIBITORY ACTIVITIES, AND USE THEREOF | Non-Final OA | Korea University Research and Business Foundation |
| 18802702 | Methods for Regulating Muscle Performance using Fat Specific Protein 27 (FSP27) Compositions | Non-Final OA | Ohio University |
| 18695739 | PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF | Non-Final OA | CAREGEN CO., LTD. |
| 18257756 | POLYPEPTIDES AND USES THEREOF | Non-Final OA | MEDIMMUNE LIMITED |
| 18552656 | Use Of Long-Acting Growth Hormone For Treating Inflammation-Induced Diseases | Non-Final OA | Ascendis Pharma A/S |
| 18040388 | ANTIMICROBIAL MATRIX FORMED FROM PEPTIDE HYDROGELS | Non-Final OA | GEL4MED, INC. |
| 18562810 | COMPOSITION COMPRISING PEDF-DERIVED SHORT PEPTIDE, PREPARATION METHOD THEREOF, AND USE THEREOF | Non-Final OA | BRIM Biotechnology, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy